Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 18;26(1):57.
doi: 10.1186/s12859-025-06075-7.

MFCADTI: improving drug-target interaction prediction by integrating multiple feature through cross attention mechanism

Affiliations

MFCADTI: improving drug-target interaction prediction by integrating multiple feature through cross attention mechanism

Na Quan et al. BMC Bioinformatics. .

Abstract

Accurately identifying potential drug-target interactions (DTIs) is a critical step in drug discovery. Multiple heterogeneous biological data provide abundant features for DTI prediction. Many computational methods have been proposed based on these data. However, most of these methods either extract features from sequences or from networks, utilizing only one aspect of the characteristics of drugs and targets, neglecting the complementary information between these two types of features. In fact, integrating different types of features will provide more valuable information for DTI prediction. In this article, we propose a novel method to improve the predictive capability for DTIs, named MFCADTI, by integrating multi-source feature through cross-attention mechanisms. The method extracts network topological features from the heterogeneous network and attribute features from sequences of drugs and targets. Considering the complementarity and heterogeneity between network and attribute features, cross-attention mechanisms are used to integrate the network and attribute features of drugs and targets. To capture the correlations between drugs and targets, cross-attention is used to learn the interaction features of each drug-target pair. We evaluate MFCADTI on two datasets and experimental results demonstrate a significant improvement in the performance of MFCADTI compared to state-of-the-art methods. Finally, case studies illustrate that MFCADTI is an effective DTI prediction way that provides valuable guidance for drug development. The data and source code used in this study are available at: https://github.com/Dejavun/MFCADTI .

Keywords: Attribute feature; Cross-attention; Drug-target interaction prediction; Feature fusion; Network feature.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The framework of MFCADTI. The MFCADTI framework consists of three parts: network feature extraction, attribute feature extraction, and cross-attention feature fusion and prediction
Fig. 2
Fig. 2
Performance comparison with baselines
Fig. 3
Fig. 3
Comparison of different network features
Fig. 4
Fig. 4
Comparison of different sequence encoding methods
Fig. 5
Fig. 5
Prediction performance with different cold start experimental settings on two datasets

References

    1. Sachdev K, Gupta MK. A comprehensive review of feature based methods for drug target interaction prediction. J Biomed Inf. 2019;93:103159. - PubMed
    1. Chen X, Yan CC, Zhang X, et al. Drug-target interaction prediction: databases, web servers and computational models. Brief Bioinf. 2016;17(4):696–712. - PubMed
    1. Wu L, Shen Y, Li M, Wu FX. Network output controllability-based method for drug target identification. IEEE Trans Nanobiosci. 2015;14(2):184–91. - PubMed
    1. Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175–81. - PMC - PubMed
    1. Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–91. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources